[AsCNP_P4] Poster Session 4
Bipolar Disorders 1

[AsCNP-P4-2] Safety and Tolerability of Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled 6-week Study (ELEVATE study)

^○Takahiro MASUDA¹, Jun ISHIGOOKA², Tadafumi KATO³, Kei WATABE¹, Mari MIYAJIMA¹, Teruhiko HIGUCHI^{4, 5} (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. Institute of CNS Pharmacology, Japan, 3. RIKEN Brain Science Institute, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)